1224464-97-4

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 6-chloro-4-Methylnicotinate is used as an intermediate in the synthesis of various drugs for its potential applications in treating different health conditions.
Used in Drug Synthesis:
Methyl 6-chloro-4-Methylnicotinate is used as a key component in the development of new pharmaceutical compounds, contributing to the advancement of drug discovery and innovation.
Used in Research and Development:
Methyl 6-chloro-4-Methylnicotinate is utilized in research and development efforts to explore its potential applications and optimize its use in the pharmaceutical field, enhancing the understanding of its properties and benefits.

Upstream product

• 67-56-1 methanol 
• 503555-50-8 6-chloro-4-methylpyridine-3-carboxylic acid 
• 1224465-02-4 5-methoxycarbonyl-4-methyl-2-hydroxypyridine 

Downstream Products

• 1430058-68-6 2-[(2S)-2-(6-chloro-3-oxo-1,3-dihydro-2H-pyrrolo[3,4-c]pyridin-2-yl)-3-(3-fluorophenyl)propyl]-1H-isoindole-1,3(2H)-dione 
• 1430057-35-4 2-[(1S)-2-amino-1-(3-fluorobenzyl)ethyl]-6-(4-chloro-1-methyl-1H-pyrazol-5-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one 
• 1430058-70-0 6-chloro-2-[(1S)-1-(3,5-difluorobenzyl)-2-hydroxyethyl]-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one 
• 1430058-71-1 2-[(2S)-2-(6-chloro-3-oxo-1,3-dihydro-2H-pyrrolo[3,4-c]pyridin-2-yl)-3-(3,5-difluorophenyl)propyl]-1H-isoindole-1,3(2H)-dione 
• 1430058-98-2 2-[(2S)-2-(6-chloro-3-oxo-1,3-dihydro-2H-pyrrolo[3,4-c]pyridin-2-yl)-3-cyclohexylpropyl]-1H-isoindole-1,3(2H)-dione 
• 1430057-79-6 2-[(1S)-2-amino-1-(cyclohexylmethyl)ethyl]-6-(1-methyl-1H-pyrazol-5-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one 
• 1430059-00-9 C₂₈H₂₉N₅O₃ 
• 1383816-90-7 methyl 2-(3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)-4-fluorobenzo[d]thiazole-6-carboxylate 
• 1224464-98-5 methyl 6-((5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)-4-methylnicotinate 

Relevant academic research and scientific papers

INDAZOLES AS LRRK2 INHIBITORS

The present invention is directed to indazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.

Small molecule antagonist of leukocyte function associated antigen-1 (LFA-1): Structure-activity relationships leading to the identification of 6-((5 S,9 R)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7- triazaspiro[4.4]nonan-7-yl)nico

Leukocyte function-associated antigen-1 (LFA-1), also known as CD11a/CD18 or αLβ2, belongs to the β2 integrin subfamily and is constitutively expressed on all leukocytes. The major ligands of LFA-1 include three intercellu